Novavax faces renewed attack by Shah Capital after AGM

Shah Capital, the largest shareholder of Novavax (NVAX), criticized the company’s leadership on Wednesday, even after the ...
Benzinga.com

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment

Novavax CEO John C. Jacobs called the decision "a significant milestone" and emphasized the company's commitment to vulnerable populations. The CDC has noted that these groups will most likely seek ...
Hosted on MSN

Novavax outlines $1.04B–$1.06B 2025 revenue framework and targets non-GAAP profitability as early as 2028 amid partnership-driven transition

John Jacobs, President, CEO & Director, stated that Novavax has made significant progress in Q3 by strengthening existing partnerships and building new collaborations while advancing R&D innovation ...